Insiders · NMTC

NMTC insider transactions

NeuroOne Medical Technologies Corporation (NMTC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NMTC

• 18d
  SEC Form 4 filed by Mills Jason Richard

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 18d
  SEC Form 4 filed by Mathiesen Jeffrey S

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 18d
  SEC Form 4 filed by Buckman Paul

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 18d
  SEC Form 4 filed by Andrle Edward

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 24d
  SEC Form 4 filed by Christianson Mark

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 24d
  SEC Form 4 filed by Mertens Steve

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 24d
  SEC Form 4 filed by Rosa David A

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 40d
  Business Development Director Christianson Mark sold $734 worth of shares (917 units at $0.80), decreasing direct ownership by 0.43% to 214,283 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 44d
  Business Development Director Christianson Mark sold $10,976 worth of shares (13,720 units at $0.80), decreasing direct ownership by 6% to 215,200 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 54d
  Chief Business Officer Wambeke David J. bought $670,400 worth of shares (1,000,000 units at $0.67) (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 54d
  SEC Form 3 filed by new insider Wambeke David J.

  3 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 64d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 7,376 shares, decreasing direct ownership by 5% to 153,047 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 64d
  Business Development Director Christianson Mark covered exercise/tax liability with 1,812 shares, decreasing direct ownership by 0.79% to 228,920 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 64d
  CEO and President Rosa David A covered exercise/tax liability with 71,325 shares, decreasing direct ownership by 6% to 1,082,590 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 110d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 906 shares, decreasing direct ownership by 0.56% to 160,423 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 110d
  CEO and President Rosa David A increased direct ownership by 0.21% to 1,153,915 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 110d
  Business Development Director Christianson Mark covered exercise/tax liability with 253 shares, decreasing direct ownership by 0.11% to 230,732 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 113d
  Director Mills Jason Richard was granted 7,758 shares (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 113d
  SEC Form 3 filed by new insider Mills Jason Richard

  3 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 206d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 906 shares, decreasing direct ownership by 0.56% to 161,329 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 206d
  Business Development Director Christianson Mark covered exercise/tax liability with 253 shares, decreasing direct ownership by 0.11% to 230,985 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 206d
  CEO and President Rosa David A covered exercise/tax liability with 2,458 shares, decreasing direct ownership by 0.21% to 1,156,373 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 228d
  Business Development Director Christianson Mark sold $22,203 worth of shares (30,000 units at $0.74), decreasing direct ownership by 11% to 231,238 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 297d
  Business Development Director Christianson Mark covered exercise/tax liability with 253 shares, decreasing direct ownership by 0.10% to 261,238 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 298d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 906 shares, decreasing direct ownership by 0.56% to 162,235 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 298d
  CEO and President Rosa David A covered exercise/tax liability with 2,458 shares, decreasing direct ownership by 0.21% to 1,158,831 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 304d
  SEC Form 4 filed by Director Mathiesen Jeffrey S

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 304d
  SEC Form 4 filed by Director Buckman Paul

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 304d
  SEC Form 4 filed by Director Andrle Edward

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 324d
  Business Development Director Christianson Mark sold $5,804 worth of shares (10,000 units at $0.58), decreasing direct ownership by 4% to 261,491 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 326d
  SEC Form 4 filed by General Counsel Johns Emily J.

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 326d
  SEC Form 3 filed by new insider Johns Emily J.

  3 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 337d
  Business Development Director Christianson Mark sold $5,596 worth of shares (8,981 units at $0.62), decreasing direct ownership by 3% to 271,491 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 339d
  Business Development Director Christianson Mark sold $7,306 worth of shares (11,019 units at $0.66), decreasing direct ownership by 4% to 280,472 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 369d
  SEC Form 4 filed by Business Development Director Christianson Mark

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 369d
  SEC Form 4 filed by Chief Technology Officer Mertens Steve

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 369d
  SEC Form 4 filed by Chief Operating Officer Volker Christopher

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 369d
  SEC Form 4 filed by Chief Financial Officer Mcclurg Ronald W.

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 369d
  SEC Form 4 filed by CEO and President Rosa David A

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 383d
  Chief Financial Officer Mcclurg Ronald W. bought $100,000 worth of shares (200,000 units at $0.50), increasing direct ownership by 82% to 444,117 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 383d
  CEO and President Rosa David A bought $50,000 worth of shares (100,000 units at $0.50), increasing direct ownership by 9% to 1,161,289 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 388d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 906 shares, decreasing direct ownership by 0.55% to 163,141 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 388d
  Business Development Director Christianson Mark covered exercise/tax liability with 253 shares, decreasing direct ownership by 0.09% to 291,491 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 388d
  CEO and President Rosa David A covered exercise/tax liability with 2,458 shares, decreasing direct ownership by 0.23% to 1,061,289 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 429d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 7,376 shares, decreasing direct ownership by 4% to 164,047 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 429d
  Business Development Director Christianson Mark covered exercise/tax liability with 1,812 shares, decreasing direct ownership by 0.62% to 291,744 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 429d
  CEO and President Rosa David A covered exercise/tax liability with 71,325 shares, decreasing direct ownership by 6% to 1,063,747 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 430d
  Director Buckman Paul was granted 27,778 shares, increasing direct ownership by 25% to 136,804 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 430d
  Director Andrle Edward was granted 27,778 shares, increasing direct ownership by 43% to 92,003 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 430d
  Director Mathiesen Jeffrey S was granted 27,778 shares, increasing direct ownership by 32% to 114,414 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 445d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 252 shares, decreasing direct ownership by 0.15% to 171,423 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 445d
  Business Development Director Christianson Mark covered exercise/tax liability with 90 shares, decreasing direct ownership by 0.03% to 293,556 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 445d
  CEO and President Rosa David A covered exercise/tax liability with 2,239 shares, decreasing direct ownership by 0.20% to 1,135,072 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 477d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 1,158 shares, decreasing direct ownership by 0.67% to 171,675 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 477d
  Business Development Director Christianson Mark covered exercise/tax liability with 343 shares, decreasing direct ownership by 0.12% to 293,646 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 477d
  CEO and President Rosa David A covered exercise/tax liability with 4,697 shares, decreasing direct ownership by 0.41% to 1,137,311 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 508d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 252 shares, decreasing direct ownership by 0.15% to 172,833 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 508d
  Business Development Director Christianson Mark covered exercise/tax liability with 90 shares, decreasing direct ownership by 0.03% to 293,989 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 508d
  CEO and President Rosa David A covered exercise/tax liability with 2,239 shares, decreasing direct ownership by 0.20% to 1,142,008 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
• 540d
  Chief Technology Officer Mertens Steve covered exercise/tax liability with 252 shares, decreasing direct ownership by 0.15% to 173,085 units (SEC Form 4)

  4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)